Akers Biosciences Inc. (AKER): Price and Financial Metrics


Akers Biosciences Inc. (AKER)

Today's Latest Price: $2.04 USD

0.02 (0.99%)

Updated Dec 4 4:00pm

Add AKER to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 369 in Miscellaneous

See all "A" rated Strong Buy stocks

AKER Stock Summary

  • With a year-over-year growth in debt of -85.02%, Akers Biosciences Inc's debt growth rate surpasses merely 2.64% of about US stocks.
  • Revenue growth over the past 12 months for Akers Biosciences Inc comes in at -75.17%, a number that bests just 2.19% of the US stocks we're tracking.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for AKER comes in at -119.12% -- higher than that of only 3.2% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Akers Biosciences Inc, a group of peers worth examining would be ADXS, AKBA, AUMN, NOVN, and MNDO.
  • Visit AKER's SEC page to see the company's official filings. To visit the company's web site, go to www.akersbio.com.

AKER Stock Price Chart Interactive Chart >

Price chart for AKER

AKER Price/Volume Stats

Current price $2.04 52-week high $8.85
Prev. close $2.02 52-week low $1.55
Day low $1.97 Volume 421,500
Day high $2.05 Avg. volume 1,438,470
50-day MA $2.07 Dividend yield N/A
200-day MA $3.20 Market Cap 18.07M

AKER Latest News Stream


Event/Time News Detail
Loading, please wait...

AKER Latest Social Stream


Loading social stream, please wait...

View Full AKER Social Stream

Latest AKER News From Around the Web

Below are the latest news stories about Akers Biosciences Inc that investors may wish to consider to help them evaluate AKER as an investment opportunity.

Akers Biosciences down 28% on early data on COVID-19 vaccine candidate

Nano cap Akers Biosciences ([[AKER]] -28.1%) slumps on more than a 5x surge in volume in reaction to proof-of-concept data from animal studies assessing the safety and immunogenicity of its SARS-CoV-2 vaccine candidate, dubbed PRAK3202, that it is co-developing with Premas Biotech.The company says the vaccine was well-tolerated and induced...

Seeking Alpha | August 27, 2020

Akers Biosciences raises $6.8M in equity

Akers Biosciences ([[AKER]] -14.6%) has entered into agreements for the purchase and sale of 1.21M shares at $5.67/share, in a registered direct offering, for gross proceeds of $6.8M.The offering is expected to complete by August 13....

Seeking Alpha | August 11, 2020

Why Akers Biosciences Is Trading Higher Today

Akers Biosciences Inc (NASDAQ: AKER ) shares are trading higher … Full story available on Benzinga.com

Benzinga Feeds | July 20, 2020

Akers Biosciences and Premas Biotech Announce Initiation of Animal Studies

Akers Biosciences, Inc. (the “Company”) (AKER), a developer of rapid health information technologies, today announced with its partner, Premas Biotech, the initiation of animal studies for its SARS-CoV-2 vaccine candidate in India. Premas has successfully completed the manufacturing process for the VLP (virus like particle) vaccine candidate, including three antigens from SARS-CoV-2. Premas plans to administer the test across different dose amounts, including amounts that would be applicable to humans.

Yahoo | July 7, 2020

Hedge Funds Are Nibbling On Akers Biosciences Inc (AKER)

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]

Yahoo | May 29, 2020

Read More 'AKER' Stories Here

AKER Price Returns

1-mo 12.09%
3-mo -8.11%
6-mo -44.72%
1-year -32.23%
3-year -97.59%
5-year -99.30%
YTD -36.25%
2019 -88.20%
2018 8.65%
2017 -93.16%
2016 57.02%
2015 -69.67%

Continue Researching AKER

Want to see what other sources are saying about Akers Biosciences Inc's financials and stock price? Try the links below:

Akers Biosciences Inc (AKER) Stock Price | Nasdaq
Akers Biosciences Inc (AKER) Stock Quote, History and News - Yahoo Finance
Akers Biosciences Inc (AKER) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8132 seconds.